Molecular characterization of acute myeloid leukemia patients who relapse more than 3 years after diagnosis: an exome sequencing study of 31 patients

José Andrés Vázquez · Haematologica · 2019

Summary

NPM1 mutations and FLT3-ITD were identified by routine diagnostics as exome sequencing is not reliable for the detection of these types of aberrations and gene mutations specifically driving AML relapse remain uncertain as previous studies did not identify a general relapse mechanism.

Type: article
Published: 2019-08-01
Cited by: 2
References: 19
Access: Open access
DOI: https://doi.org/10.3324/haematol.2019.227702
PubMed: https://pubmed.ncbi.nlm.nih.gov/31371420/
OpenAlex: https://openalex.org/W31371420
Semantic Scholar: https://api.semanticscholar.org/CorpusID:87904700

Keywords

Philosophy

References

Potential cure of acute myeloid leukemiaMasamitsu Yanada, Guillermo Garcia‐Manero, Gautam Borthakur — 2007
Late relapses in acute myeloid leukemia: analysis of characteristics and outcomeDushyant Verma, Hagop M. Kantarjian, Stefan Faderl — 2010
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.Frank G. Rücker, Richard F. Schlenk, Lars Bullinger — 2012
Morphologic dysplasia in acute myeloid leukemia: importance of granulocytic dysplasia.John M. Bennett — 2003
A method and server for predicting damaging missense mutationsIvan Adzhubei, Steffen Schmidt, Leonid Peshkin — 2010
Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia.Wolfgang Kern, Daniela Voskova, Claudia Schoch — 2004
Clonal evolution in hematologic malignancies and therapeutic implicationsDan A. Landau, S L Carter, Gaddy Getz — 2013
Younger adults with acute myeloid leukemia in remission for ≥3 years have a high likelihood of cure: the ECOG experience in over 1200 patientsJustin M. Watts, Victoria Wang, Mark R. Litzow — 2014
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.David Grimwade, Adam Ivey, Brian J.P. Huntly — 2016
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML.Terrence N. Wong, Christopher A. Miller, Jeffery M. Klco — 2016
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemiaSheng Li, Francine E. Garrett-Bakelman, Stephen S. Chung — 2016
Genomic Classification in Acute Myeloid Leukemia.Elli Papaemmanuil, Hartmut Döhner, Peter J Campbell — 2016
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Hartmut Döhner, Elihu H. Estey, David Grimwade — 2017
Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 PatientsPhilipp A. Greif, Luise Hartmann, Sebastian Vosberg — 2018
NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse.Alexander Höllein, Manja Meggendorfer, Frank Dicker — 2018
More Than 10% of NPM1-Mutated AML Relapses Occur after 5 Years from Complete RemissionSarah Bertoli, Suzanne Tavitian, Emilie Bérard — 2018
Acute myeloid leukemiaRichard M. Stone, Margaret O’Donnell, Mikkael A. Sekeres — 2004
Clonal evolution in relapsed NPM1 mutated acute myeloid leukemiaUku. Innere Medizin — 2014

Cited by

Bericht über die 33. Tumorgenetische Arbeitstagung (TGA) vom 19.-21.5.20212021
Relapse-specific genetic patterns in the exomic mutational landscape in acute myeloid leukemiaWardah Qureshi, Aisha Jamal, Atia Gohar — 2025

Related papers

No related papers recorded.